In particular, diminished levels of RUNX3 in lung tissue from patients with BPD may induce epithelial-mesenchymal transition (EMT) in alveolar type II (AT2) cells, negatively impacting alveolar growth (48). Here, RUNX3 is linked to bronchopulmonary dysplasia.